Literature DB >> 1767532

Cellular physiology and pathophysiology of the parathyroid glands.

G Akerström1, J Rastad, S Ljunghall, P Ridefelt, C Juhlin, E Gylfe.   

Abstract

This report provides insight into parathyroid gland physiology and the pathophysiology of hyperparathyroidism (HPT). Increases in the extracellular calcium concentration constitute the primary physiological signal for inhibition of parathyroid hormone (PTH) release. Transduction of the external signal into a cellular response involves activation of a cation receptor mechanism on the plasma membrane with rapid rise in the cytoplasmic calcium concentration of the cells. This recently discovered parathyroid calcium receptor has been characterized as a glycoprotein of unusually high molecular weight, which may play a key role in calcium homeostasis since it is also expressed in the kidney and placenta. Binding of external calcium to the receptor is associated with mobilization of intracellular calcium as well as calcium influx into the cells and phosphoinositol hydrolysis. These events rapidly interfere with the release process through essentially unknown mechanisms and probably also at sustained stimulation inhibit PTH gene transcription. The relative calcium insensitivity of the PTH release in HPT is associated with a deranged regulation of cytoplasmic calcium within pathological parathyroid cells. The molecular basis for this disturbance comprises down regulation of the cation receptor, whereby external calcium is translated into abnormally low levels of cytoplasmic calcium and insufficient inhibition of PTH release. Studies on expression of the functionally important cation sensing glycoprotein and its associated cellular signal systems may provide novel means for interference with the pathophysiological derangements of HPT.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1767532     DOI: 10.1007/bf01665299

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  86 in total

1.  Genetic abnormalities in sporadic parathyroid adenomas.

Authors:  E Friedman; A E Bale; S J Marx; J A Norton; A Arnold; T Tu; G D Aurbach; A M Spiegel
Journal:  J Clin Endocrinol Metab       Date:  1990-08       Impact factor: 5.958

Review 2.  The biosynthesis, intracellular processing, and secretion of parathormone.

Authors:  D V Cohn; R R MacGregor
Journal:  Endocr Rev       Date:  1981       Impact factor: 19.871

3.  Control of secretion of parathyroid hormone in secondary hyperparathyroidism.

Authors:  S Adami; N Muirhead; R M Manning; J H Gleed; S E Papapoulos; L M Sandler; G R Catto; J L O'Riordan
Journal:  Clin Endocrinol (Oxf)       Date:  1982-05       Impact factor: 3.478

4.  Regulation of parathyroid hormone release in primary and secondary hyperparathyroidism - studies in vivo and in vitro.

Authors:  C Rudberg; G Akerström; S Ljunghall; L Grimelius; H Johansson; H Pertoft; L Wide
Journal:  Acta Endocrinol (Copenh)       Date:  1982-11

5.  The acute secretory response to alterations in extracellular calcium concentration and dopamine in perifused bovine parathyroid cells.

Authors:  E M Brown; R Leombruno; J Thatcher; M Burrowes
Journal:  Endocrinology       Date:  1985-03       Impact factor: 4.736

6.  Interaction of monoclonal antiparathyroid antibody with Ca2+ agonistic actions of Mn2+ in normal human parathyroid cells.

Authors:  H Johansson; R Larsson; C Juhlin; J Rastad; G Akerström; E Gylfe
Journal:  Cell Calcium       Date:  1989-01       Impact factor: 6.817

7.  High calcium and other divalent cations increase inositol trisphosphate in bovine parathyroid cells.

Authors:  D M Shoback; L A Membreno; J G McGhee
Journal:  Endocrinology       Date:  1988-07       Impact factor: 4.736

8.  Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium.

Authors:  J A Delmez; C Tindira; P Grooms; A Dusso; D W Windus; E Slatopolsky
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

9.  Endogenous substrates for cAMP-dependent phosphorylation in dispersed bovine parathyroid cells.

Authors:  R D Lasker; A M Spiegel
Journal:  Endocrinology       Date:  1982-10       Impact factor: 4.736

10.  Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies.

Authors:  C Juhlin; L Klareskog; P Nygren; S Ljunghall; E Gylfe; J Rastad; G Akerström
Journal:  Endocrinology       Date:  1988-06       Impact factor: 4.736

View more
  3 in total

1.  Pharmacodynamic behaviour of vecuronium in primary hyperparathyroidism.

Authors:  E J Roland; J M Wierda; B G Eurin; E Roupie
Journal:  Can J Anaesth       Date:  1994-08       Impact factor: 5.063

2.  Graft-dependent renal hyperparathyroidism despite successful kidney transplantation.

Authors:  K Schlosser; M Rothmund; K Maschuw; P J Barth; T P Vahl; K L Suchan; E Domínguez Fernández
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

3.  Subtotal parathyroidectomy for secondary renal hyperparathyroidism: a 20-year surgical outcome study.

Authors:  Aleksander Konturek; Marcin Barczyński; Małgorzata Stopa; Wojciech Nowak
Journal:  Langenbecks Arch Surg       Date:  2016-05-27       Impact factor: 3.445

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.